|
-
Peter J. Koehler
Some time ago, I wrote about brain stones, intracranial calcifications that have been found at autopsies for many centuries. In this context, the pineal gland was in the spotlight after the French philosopher René Descartes (1596-1650) wrote down his ideas about the physical part of the soul supposedly localized in this structure.
In the subsequent 150 years, there were lively discussions between physicians, who were proponents and opponents of this idea.
-
By Dr. Aida Suárez-González, Prof. Morris Freedman, Prof. Manabu Ikeda, Dr. Yutaka Tanaka, Prof. Masaru Mimura, and Prof. Suvarna Alladi.
The attendants for the 2024 biennial meeting of the WFN Aphasia, Dementia, and Cognitive Disorders Specialty Group (ADCD SG) arrived in Nara, Japan, about the same time as the sakura (Japanese cherry trees) reached full bloom. This served as a timely metaphor to usher in the four vibrant days of all things cognitive neurology that followed, elegantly wrapped in the most exquisite Japanese hospitality.
Open latest issue
|
-
Benedict Kleiser, David Hoffmann, Markus C. Kowarik, Evelyn Dubois, Marcel Armbruster, Alexander Grimm, Justus Marquetand
Journal of the Neurological Sciences. REVIEW ARTICLE| VOLUME 466, 123213, November 15, 2024
Myositis-specific antibodies (MSAs) and myositis-associated antibodies (MAAs) are assessed in clinical neurology, serving as a non-invasive tool for the differential diagnosis of autoimmune myopathies. However, the presence of MSAs and MAAs in neurological disorders remains uncertain.
-
Gabriela Petersen, Eduardo Ortega-Matute, Daniela Perez-Nieto, Andrés Inzunza, Victor Garcia Navarro
Journal of the Neurological Sciences. REVIEW ARTICLE| VOLUME 466, 123213, November 15, 2024
Hydrocephalus is a clinical and neurologic condition characterized by an abnormal accumulation of cerebrospinal fluid (CSF). Imaging studies often reveal a disproportionate increase in subarachnoid space and ventricular size relative to brain volume, with normal CSF pressure during lumbar puncture.
There is increasing evidence that environmental and lifestyle factors are not only important in triggering MS but are also implicated in MS progression.
Open latest issue
|
OPEN ACCESS JOURNAL
-
Sharifi P, Rezaeimanesh N, Moradi A, Moghadasi AN.
eNeurologicalSci. 2024 Jun 12:100511.
Patients with multiple sclerosis (MS) are at higher risk of having infections due to receiving disease modifying therapies. The current study was conducted among Iranian MS patients who had experienced at least one episode of COVID-19 infection in order to evaluate the effects of COVID-19 vaccination on symptoms of their infection. Data on demographic information, MS characteristics, COVID-19 infection details, and vaccination status were collected. Statistical analyses, were performed to evaluate the association between vaccination and symptoms of COVID-19 infection.
COVID-19 vaccination can reduce the incidence of respiratory symptoms and headaches in MS patients during COVID-19 infection episodes. Additionally, patients who are receiving immunosuppressive drugs may benefit from COVID-19 vaccination.
-
Galetaki D, Szymczuk V, Shi M, Merchant N
eNeurologicalSci. 2024 Jun 15:100513.
Glucocorticoids are standard of care for patients with Duchenne muscular dystrophy (DMD). Although prolonged exposure is associated with multiple endocrine side effects, current guidelines related to monitoring and management of endocrinopathies are suboptimal. We aim to explore community perceptions of endocrine related complications in patients with DMD, assess current level of understanding, and desire for further education.
A 31-item online survey was sent through Parent Project to Muscular Dystrophy (PPMD) to Duchenne Registry members to be completed by patients or their caretakers.
Open latest issue
|
